LPL Financial’s Supernus Pharmaceuticals SUPN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $520K | Buy |
|
|||||
|
2025
Q1 | $526K | Buy |
|
|||||
|
2024
Q4 | $461K | Buy |
|
|||||
|
2024
Q3 | $334K | Buy |
|
|||||
|
2024
Q2 | $272K | Buy |
|
|||||
|
2024
Q1 | $253K | Buy |
|
|||||
|
2023
Q3 | – | Sell |
|
|||||
|
2023
Q2 | $223K | Sell |
|
|||||
|
2023
Q1 | $314K | Sell |
|
|||||
|
2022
Q4 | $337K | Sell |
|
|||||
|
2022
Q3 | $641K | Sell |
|
|||||
|
2022
Q2 | $680K | Buy |
|
|||||
|
2022
Q1 | $699K | Buy |
|
|||||
|
2021
Q4 | $629K | Buy |
|
|||||
|
2021
Q3 | $529K | Buy |
|
|||||
|
2021
Q2 | $568K | Sell |
|
|||||
|
2021
Q1 | $545K | Buy |
|
|||||
|
2020
Q4 | $426K | Buy |
|
|||||
|
2020
Q3 | $328K | Sell |
|
|||||
|
2020
Q2 | $377K | Buy |
|
|||||
|
2020
Q1 | $273K | Sell |
|
|||||
|
2019
Q4 | $369K | Sell |
|
|||||
|
2019
Q3 | $431K | Sell |
|
|||||
|
2019
Q2 | $523K | Sell |
|
|||||
|
2019
Q1 | $860K | Sell |
|
|||||
|
2018
Q4 | $910K | Buy |
|
|||||
|
2018
Q3 | $1.29M | Sell |
|
|||||
|
2018
Q2 | $2.66M | Buy |
|
|||||
|
2018
Q1 | $917K | Sell |
|
|||||
|
2017
Q4 | $842K | Sell |
|
|||||
|
2017
Q3 | $898K | Buy |
|
|||||
|
2017
Q2 | $869K | Buy |
|
|||||
|
2017
Q1 | $618K | Sell |
|
|||||
|
2016
Q4 | $628K | Sell |
|
|||||
|
2016
Q3 | $950K | Sell |
|
|||||
|
2016
Q2 | $905K | Sell |
|
|||||
|
2016
Q1 | $946K | Buy |
|
|||||
|
2015
Q4 | $517K | Buy |
|
|||||
|
2015
Q3 | $429K | Buy |
|